Inflection Point Ventures (IPV), an early-stage investment firm, said it recorded 14 exits in 2024 with an approximate 36% internal rate of return. The company stated its portfolio has achieved 47 exits from more than 200 startups over five years.
According to IPV, notable exits included Prescinto AI’s acquisition by IBM and Parablu’s sale to CrashPlan. The firm reported that portfolio companies Aksum, Conscious Chemist and Qubehealth delivered IRRs exceeding 50%.
“Our focus has always been on identifying and supporting businesses with the potential to scale and deliver strong returns,” said Vinay Bansal, Founder & CEO of IPV.
The company said its portfolio startups secured 25 follow-on funding rounds in 2024 from investors including Goodwater Capital, Blume Ventures and Vertex Ventures. IPV stated that two of its portfolio companies appeared on Shark Tank India.
The exits included blended transactions that the company said offered investors optional liquidity at 30-40% IRRs. “By consistently identifying high-growth potential and fostering strategic relationships, we ensure that our investors benefit from both capital appreciation and early liquidity,” said Ankur Mittal, Co-founder of IPV.
IPV cited IBM’s acquisition of Prescinto AI and CrashPlan’s purchase of Parablu as strategic deals that delivered approximately 30% IRR each. The company said these exits demonstrated its portfolio’s attractiveness to acquirers.
The firm’s performance comes amid what industry reports describe as challenging market conditions for startup exits. According to a report by IVCA and EY referenced by IPV, only 10-15% of Indian startups typically provide successful exits to investors.
“We actively support our startups in scaling and securing strategic exits,” said Mitesh Shah, IPV Co-founder, describing the firm’s approach to portfolio management.
